Cindy Perettie

Cindy Perettie

Executive Vice President and Global Head of Kite

Gilead Sciences (Kite Pharma)
Bringing Business and Global Health, Cindy Perettie, Executive VP of Kite, Shares a Journey of Science and Business to Provide World-class Treatment

With a profound knowledge and interest in science, Cindy Perettie spent many of her working years learning how to apply this to roles in the corporate world. 

Her journey began with Bachelor’s of Science in Biology and a Minor in Chemistry, which allowed her to begin her pursuit of work in research and discovery. 

Her first working role as a Senior Research Associate for the Johns Hopkins University led her down a path to learn more about the business aspects of pharmaceuticals, which led to her current role as the Executive VP of Kite. However, on this path there were many steps to take as Perettie evolved to meet the needs of companies like Chiron Corporation, Genentech, Roche and Foundation Medicine

To fulfil her need for business knowledge, she later underwent a Master’s in Business Administration, which helped form her understanding of the corporate environment and how it aligns with global health and sustainability. 

The key challenges of her current role are twofold as Perettie not only has to engage in commercial activities, but do so without compromising the core mission of delivering treatment to lymphoma patients in the fastest time possible. 

“As a head of a company, there's the challenges of balancing delivery on the business side while ensuring we continue to engage employees and really do what's right, not just for patients but for society,” says Perettie. 

In terms of her role at Kite, she says: “We have been focused on delivering our CAR T therapy, not just at academic medical centres but also closer to where patients live in the community—and that's been a challenge that we’ve tackled over the course of the last year.”

Truly driven by the end goal of Kite, Perettie attributes her greatest inspiration to the patients that she and Kite. The criticality of their illnesses and their ability to tackle their diseases head-on is what makes her want to get to work harder and ensure the best outcomes for them. 

“It requires resilience, so be in it for the long game.”

Read the full story HERE.

Make sure you check out the latest edition of Technology Magazine and also sign up to our global conference series - Tech & AI LIVE 2024

**************

Technology Magazine is a BizClik brand ​​​​​​​

Gilead Sciences (Kite Pharma)
Gilead Sciences (Kite Pharma)
Share

Featured Interviews

Featured

Jordan Ruting

Head of Channel Sales at SAP America

Head of Channel Sales at SAP America

Read More

Greg Wilson

Microsoft Worldwide Public Sector’s Chief Technology Officer for Government

Microsoft Government CTO on the company's expansive role in AI adoption, Cloud migration, ethical governance, and cybersecurity within the public sector

Read More
“For me, we're so much more than a large technology company. There's a responsibility on us as a strategic partner to nations, and as a partner to governments.”
Greg Wilson
Microsoft Worldwide Public Sector’s Chief Technology Officer for Government

Garrett Olson

Wolt’s Head of Insurance and Risk

Technology company Wolt’s Head of Insurance and Risk Garrett Olson explains the insurance needs of Wolt’s 180,000+ courier partners

Read More

Kate Maxwell

Chief Technology Officer for Microsoft’s Worldwide Defense and Intelligence Industry

As the global landscape evolves at an unprecedented pace, Microsoft is helping defence and intelligence clients with game-changing capabilities

Read More

Ashley Naughton

Automotive Logistics Director at McLaren

McLaren Automotive Logistics Director Ashley Naughton on why the company is a perfect match for his skills and passions

Read More

Jordan Ruting

Head of Channel Sales at SAP America

Head of Channel Sales at SAP America

Read More